130 related articles for article (PubMed ID: 28987672)
21. Quantitative analysis of dynamic contrast enhanced MRI for assessment of bowel inflammation in Crohn's disease pilot study.
Oto A; Fan X; Mustafi D; Jansen SA; Karczmar GS; Rubin DT; Kayhan A
Acad Radiol; 2009 Oct; 16(10):1223-30. PubMed ID: 19524458
[TBL] [Abstract][Full Text] [Related]
22. Soft tissue sarcoma: correlation of dynamic contrast-enhanced magnetic resonance imaging features with HIF-1α expression and patient outcomes.
Li X; Xie Y; Hu Y; Lu R; Li Q; Xiong B; Tao H; Chen S
Quant Imaging Med Surg; 2022 Oct; 12(10):4823-4836. PubMed ID: 36185052
[TBL] [Abstract][Full Text] [Related]
23. Assessment of therapeutic response in Crohn's disease using quantitative dynamic contrast enhanced MRI (DCE-MRI) parameters: A preliminary study.
Zhu J; Zhang F; Zhou J; Li H
Medicine (Baltimore); 2017 Aug; 96(32):e7759. PubMed ID: 28796069
[TBL] [Abstract][Full Text] [Related]
24. Dynamic contrast-enhanced MR imaging pharmacokinetic parameters as predictors of treatment response of brain metastases in patients with lung cancer.
Kuchcinski G; Le Rhun E; Cortot AB; Drumez E; Duhal R; Lalisse M; Dumont J; Lopes R; Pruvo JP; Leclerc X; Delmaire C
Eur Radiol; 2017 Sep; 27(9):3733-3743. PubMed ID: 28210799
[TBL] [Abstract][Full Text] [Related]
25. Prediction of the response of ocular adnexal lymphoma to chemotherapy using combined pretreatment dynamic contrast-enhanced and diffusion-weighted MRI.
Guo P; Liu Z; Yan F; Wang J; Wei L; Lv H; Wang Z; Xian J
Acta Radiol; 2016 Dec; 57(12):1490-1496. PubMed ID: 27012277
[TBL] [Abstract][Full Text] [Related]
26. Assessment of liver fibrosis using pharmacokinetic parameters of dynamic contrast-enhanced magnetic resonance imaging.
Li Z; Sun J; Chen L; Huang N; Hu P; Hu X; Han G; Zhou Y; Bai W; Niu T; Yang X
J Magn Reson Imaging; 2016 Jul; 44(1):98-104. PubMed ID: 26707910
[TBL] [Abstract][Full Text] [Related]
27. Vessel wall and adventitial DCE-MRI parameters demonstrate similar correlations with carotid plaque microvasculature on histology.
van Hoof RHM; Vöö SA; Sluimer JC; Wijnen NJA; Hermeling E; Schreuder FHBM; Truijman MTB; Cleutjens JPM; Daemen MJAP; Daemen JH; van Oostenbrugge RJ; Mess WH; Wildberger JE; Heeneman S; Kooi ME
J Magn Reson Imaging; 2017 Oct; 46(4):1053-1059. PubMed ID: 28152245
[TBL] [Abstract][Full Text] [Related]
28. Relationship between intravoxel incoherent motion diffusion-weighted MRI and dynamic contrast-enhanced MRI in tissue perfusion of cervical cancers.
Lee EY; Hui ES; Chan KK; Tse KY; Kwong WK; Chang TY; Chan Q; Khong PL
J Magn Reson Imaging; 2015 Aug; 42(2):454-9. PubMed ID: 25413245
[TBL] [Abstract][Full Text] [Related]
29. Dynamic contrast-enhanced magnetic resonance imaging as a prognostic factor in predicting event-free and overall survival in pediatric patients with osteosarcoma.
Guo J; Reddick WE; Glass JO; Ji Q; Billups CA; Wu J; Hoffer FA; Kaste SC; Jenkins JJ; Ortega Flores XC; Quintana J; Villarroel M; Daw NC
Cancer; 2012 Aug; 118(15):3776-85. PubMed ID: 22180392
[TBL] [Abstract][Full Text] [Related]
30. Differentiating between Central Nervous System Lymphoma and High-grade Glioma Using Dynamic Susceptibility Contrast and Dynamic Contrast-enhanced MR Imaging with Histogram Analysis.
Murayama K; Nishiyama Y; Hirose Y; Abe M; Ohyu S; Ninomiya A; Fukuba T; Katada K; Toyama H
Magn Reson Med Sci; 2018 Jan; 17(1):42-49. PubMed ID: 28515410
[TBL] [Abstract][Full Text] [Related]
31. DCE-MRI Quantitative Parameters as Predictors of Treatment Response in Patients With Locally Advanced Cervical Squamous Cell Carcinoma Underwent CCRT.
Liu B; Sun Z; Ma WL; Ren J; Zhang GW; Wei MQ; Hou WH; Hou BX; Wei LC; Huan Y; Zheng MW
Front Oncol; 2020; 10():585738. PubMed ID: 33194734
[TBL] [Abstract][Full Text] [Related]
32. Feasibility and value of quantitative dynamic contrast enhancement MR imaging in the evaluation of sinonasal tumors.
Xian J; Du H; Wang X; Yan F; Zhang Z; Hao H; Zhao B; Tong Y; Zhang J; Han D
Chin Med J (Engl); 2014; 127(12):2259-64. PubMed ID: 24931238
[TBL] [Abstract][Full Text] [Related]
33. Limitations of single slice dynamic contrast enhanced MR in pharmacokinetic modeling of bone sarcomas.
Toms AP; White LM; Kandel R; Bleakney RR; Noseworthy M; Lee S; Blackstein ME; Wunder J
Acta Radiol; 2009 Jun; 50(5):512-20. PubMed ID: 19431058
[TBL] [Abstract][Full Text] [Related]
34. Detection of prostate cancer in peripheral zone: comparison of MR diffusion tensor imaging, quantitative dynamic contrast-enhanced MRI, and the two techniques combined at 3.0 T.
Li C; Chen M; Li S; Zhao X; Zhang C; Luo X; Zhou C
Acta Radiol; 2014 Mar; 55(2):239-47. PubMed ID: 23892233
[TBL] [Abstract][Full Text] [Related]
35. Voxelwise comparison of perfusion parameters estimated using dynamic contrast enhanced (DCE) computed tomography and DCE-magnetic resonance imaging in locally advanced cervical cancer.
Kallehauge J; Nielsen T; Haack S; Peters DA; Mohamed S; Fokdal L; Lindegaard JC; Hansen DC; Rasmussen F; Tanderup K; Pedersen EM
Acta Oncol; 2013 Oct; 52(7):1360-8. PubMed ID: 24003852
[TBL] [Abstract][Full Text] [Related]
36. DCE-MRI of the prostate using shutter-speed vs. Tofts model for tumor characterization and assessment of aggressiveness.
Hectors SJ; Besa C; Wagner M; Jajamovich GH; Haines GK; Lewis S; Tewari A; Rastinehad A; Huang W; Taouli B
J Magn Reson Imaging; 2017 Sep; 46(3):837-849. PubMed ID: 28092414
[TBL] [Abstract][Full Text] [Related]
37. Combined diffusion-weighted imaging and dynamic contrast-enhanced MRI for differentiating radiologically indeterminate malignant from benign orbital masses.
Xu XQ; Qian W; Ma G; Hu H; Su GY; Liu H; Shi HB; Wu FY
Clin Radiol; 2017 Oct; 72(10):903.e9-903.e15. PubMed ID: 28501096
[TBL] [Abstract][Full Text] [Related]
38. [Feasibility study of dynamic contrast enhanced magnetic resonance imaging qualitative diagnosis of musculoskeletal tumors].
Zhang J; Zuo PL; Cheng KB; Yu AH; Cheng XG
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Apr; 48(2):287-91. PubMed ID: 27080283
[TBL] [Abstract][Full Text] [Related]
39. The Role of Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Predicting Treatment Response for Cervical Cancer Treated with Concurrent Chemoradiotherapy.
Lu H; Wu Y; Liu X; Huang H; Jiang H; Zhu C; Man Y; Liu P; Li X; Chen Z; Long X; Pang Q; Deng S; Gu J
Cancer Manag Res; 2021; 13():6065-6078. PubMed ID: 34377025
[TBL] [Abstract][Full Text] [Related]
40. Comparison between perfusion computed tomography and dynamic contrast-enhanced magnetic resonance imaging in assessing glioblastoma microvasculature.
Jia ZZ; Shi W; Shi JL; Shen DD; Gu HM; Zhou XJ
Eur J Radiol; 2017 Feb; 87():120-124. PubMed ID: 28034567
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
